Exosome Diagnostics, Inc. - Product Pipeline Analysis, 2016 Update

Report code: GDME103113PD

Publisher: GlobalData

Formats: PDF

Published: July 05, 2016

Number of pages: 37

Exosome Diagnostics, Inc. (Exosome Diagnostics) is a medical device company that offers diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. It provides liquid biopsy tests kits for BioFluid RNA purification, EXO50 kit for plasma, EXO60 kit for cerebro spinal fluid, and EXO70 kit for urine. Exosome Diagnostics’ services include miRNA profiling, mRNA profiling, mutation detection, and custom assay development services. The company’s activities also include disease detection, diagnosis, treatment and monitoring. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer's disease. Exosome Diagnostics is headquartered in Cambridge, Massachusetts the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Exosome Diagnostics, Inc.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reason To Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Exosome Diagnostics, Inc. Company Snapshot 6

Exosome Diagnostics, Inc. Company Overview 6

Exosome Diagnostics, Inc. Pipeline Products and Clinical Trials Overview 7

Exosome Diagnostics, Inc. – Pipeline Analysis Overview 9

Key Facts 9

Exosome Diagnostics, Inc. - Major Products and Services 10

Exosome Diagnostics, Inc. Pipeline Products by Development Stage 11

Exosome Diagnostics, Inc. Pipeline Products Overview 13

Biofluid Nucleic Acid Kit - Alzheimer's Disease 13

Biofluid Nucleic Acid Kit - Alzheimer's Disease Product Overview 13

Biofluid Nucleic Acid Kit - Cardiovascular Disease 14

Biofluid Nucleic Acid Kit - Cardiovascular Disease Product Overview 14

Biofluid Nucleic Acid Kit - Chronic Kidney Disease 15

Biofluid Nucleic Acid Kit - Chronic Kidney Disease Product Overview 15

Biofluid Nucleic Acid Kit - Parkinson's Disease 16

Biofluid Nucleic Acid Kit - Parkinson's Disease Product Overview 16

Biofluid-Based Molecular Diagnostic Test - Brain Cancer 17

Biofluid-Based Molecular Diagnostic Test - Brain Cancer Product Overview 17

Diagnostic Test - Neurodegenerative Diseases 18

Diagnostic Test - Neurodegenerative Diseases Product Overview 18

EXO1000 19

EXO1000 Product Overview 19

ExoDx Lung(EGFR) 20

ExoDx Lung(EGFR) Product Overview 20

ExoDx Lung(T790M) 21

ExoDx Lung(T790M) Product Overview 21

ExoIntelliScore Prostate 22

ExoIntelliScore Prostate Product Overview 22

Next-Generation Solid Tumor Mutation Panel 23

Next-Generation Solid Tumor Mutation Panel Product Overview 23

Prostate Cancer Liquid Biopsy Test - IVD Version 24

Prostate Cancer Liquid Biopsy Test - IVD Version Product Overview 24

Prostate Cancer Liquid Biopsy Test - LDT 25

Prostate Cancer Liquid Biopsy Test - LDT Product Overview 25

Solid Tumor Mutation Panel 26

Solid Tumor Mutation Panel Product Overview 26

Exosome Diagnostics, Inc. - Key Competitors 27

Exosome Diagnostics, Inc. - Key Employees 28

Exosome Diagnostics, Inc. - Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 30

Exosome Diagnostics, Inc., Recent Developments 30

Jun 27, 2016: Exosome Diagnostics Appoints Mario Morken as Director of Business Development 30

Jun 08, 2016: Exosome Diagnostics Presents Data on Novel Platform for Disease-Specific Exosomes 30

Jun 06, 2016: Exosome Diagnostics Announces Key Appointments to Informatics Group 31

May 23, 2016: Exosome Diagnostics Appoints John Healy as Vice President of Informatics 31

May 12, 2016: Exosome Diagnostics Discovers World’s First Kidney Transplant Rejection Signature from a Simple Urine Test 32

Apr 12, 2016: Clinical Data for World’s First Truly Non-Invasive Prostate Cancer Test Published in JAMA Oncology 32

Jan 26, 2016: ExoDx Prostate(IntelliScore): A More Precise, Genetically Informed Prostate Cancer Test from a Simple Urine Sample 34

Jan 21, 2016: Exosome Diagnostics Launches World’s First Exosomal RNA-Based Liquid Biopsy, ExoDx Lung(ALK) 35

Jan 13, 2016: Leading Liquid Biopsy Company, Exosome Diagnostics, Appoints Daniel Zabrowski as Board Member 35

Dec 22, 2015: Exosome Diagnostics Appoints Raaj Venkatesan as Vice President of Regulatory Affairs and Quality 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37

List of Tables

List of Tables

Exosome Diagnostics, Inc. Pipeline Products and Clinical Trials Overview 7

Exosome Diagnostics, Inc. Pipeline Products by Equipment Type 7

Exosome Diagnostics, Inc. Pipeline Products by Indication 8

Exosome Diagnostics, Inc., Key Facts 9

Exosome Diagnostics, Inc., Major Products and Services 10

Exosome Diagnostics, Inc. Number of Pipeline Products by Development Stage 11

Exosome Diagnostics, Inc. Pipeline Products Summary by Development Stage 12

Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Status 13

Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Description 13

Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Status 14

Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Description 14

Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Status 15

Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Description 15

Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Status 16

Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Description 16

Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Status 17

Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Description 17

Diagnostic Test - Neurodegenerative Diseases - Product Status 18

Diagnostic Test - Neurodegenerative Diseases - Product Description 18

EXO1000 - Product Status 19

EXO1000 - Product Description 19

ExoDx Lung(EGFR) - Product Status 20

ExoDx Lung(EGFR) - Product Description 20

ExoDx Lung(T790M) - Product Status 21

ExoDx Lung(T790M) - Product Description 21

ExoIntelliScore Prostate - Product Status 22

ExoIntelliScore Prostate - Product Description 22

Next-Generation Solid Tumor Mutation Panel - Product Status 23

Next-Generation Solid Tumor Mutation Panel - Product Description 23

Prostate Cancer Liquid Biopsy Test - IVD Version - Product Status 24

Prostate Cancer Liquid Biopsy Test - IVD Version - Product Description 24

Prostate Cancer Liquid Biopsy Test - LDT - Product Status 25

Prostate Cancer Liquid Biopsy Test - LDT - Product Description 25

Solid Tumor Mutation Panel - Product Status 26

Solid Tumor Mutation Panel - Product Description 26

Exosome Diagnostics, Inc., Key Employees 28

Exosome Diagnostics, Inc., Subsidiaries 29

List of Figures

List of Figures

Exosome Diagnostics, Inc. Pipeline Products by Equipment Type 8

Exosome Diagnostics, Inc. Pipeline Products by Development Stage 11

Save time and money with a subscription

Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?

To find out more, click here or call +91 (0)40 4961 4567.

Single User License
Electronic PDF copy delivered via email.

Report can be used by individual purchaser only.

$750

Site License
Electronic PDF copy delivered via email.

Report can be shared by unlimited users within one corporate location,
e.g. a regional office.

$1500

Global License
Electronic PDF copy delivered via email.

Report can be shared globally by unlimited users within the purchasing corporation
e.g. all employees of a single company.

$2250

TOP